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ABSTRACT 
Activation of the hypoxia-inducible factor (HIF)-pathway in hepatocellular carcinoma (HCC) induces therapy 
resistant tumours, characterized by increased liver progenitor cell (LPCs) characteristics and poor prognosis. We 
previously reported corresponding results in mice with HCC in which hypoxia was mimicked by prolyl hydrox-
ylase domain (PHD) inhibition. Here, we aimed at investigating whether induction of LPC characteristics occurs 
during the onset of hepatocarcinogenesis and if this is associated with activation of Notch signalling. Dieth-
eylnitrosamine (DEN) was used to induce hepatic tumours in PHD2 haplodeficient (PHD2+/-) mice which were 
euthanized at 5, 10, 15 and 17 weeks following DEN during neoplastic transformation, before tumour formation. 
Neoplasia and mRNA expression of LPC and Notch markers were evaluated by histology and qPCR on isolated 
livers. PHD2 haplodeficiency resulted in enhanced expression of HIF target genes after 17 weeks of DEN com-
pared to wild type (WT) littermates but had no effect on the onset of neoplastic transformation. The mRNA ex-
pression of Afp and Epcam was increased at all time points following DEN whereas CK19, Prom1 and Notch3 
were increased after 17 weeks of DEN, without difference between PHD2+/- and WT mice. MDR1 mRNA ex-
pression was increased in all DEN treated mice compared to saline control with increased expression in PHD2+/- 
compared to WT from 15 weeks. These results indicate that the effects of PHD2 haplodeficiency on the expres-
sion of LPC and Notch markers manifest during tumour nodule formation and not early on during neoplastic 
transformation  
 
Keywords: hepatocarcinogenesis, hypoxia, liver progenitor cells, notch, prolyl hydroxylase domain, diethyl-
nitrosamine  
 
 
INTRODUCTION 
With an estimated overall five year sur-
vival of less than 20 %, liver cancer is the 2nd 
leading cause of cancer related death world-
wide (Jemal et al., 2011). Liver tumours of-
ten arise in a background of chronic liver 
disease characterised by inflammation, si-
nusoidal capillarisation and the formation of 
fibrous septa. Moreover, when tumours out-
grow their vascular supply, newly formed 
vasculature is often structurally and func-
tionally anomalous during further tumour 
growth. These processes contribute to a re-
duced liver oxygenation early during tumour 
development and later, during tumour 
growth (Yang and Poon, 2008; Heindryckx 
et al., 2012).  
Insufficient oxygen supply results in hy-
poxia, a situation known to inhibit prolyl hy-
droxylase domain (PHD) enzyme activity, 
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causing stabilisation of the hypoxia inducible 
factor (HIF). HIF stabilisation and its nuclear 
translocation results in the transactivation of 
genes involved in cell-survival by, amongst 
others, stimulating (neo-)angiogenesis 
(through induction of pro-angiogenic factors, 
such as the vascular endothelial factor or 
Vegf), and boosting the anaerobe glucose 
metabolism (via Glucose transporter 1 or 
Glut1, phospho-fructokinase or Pfk) (Hein-
dryckx et al., 2012; Bogaerts et al., 2014, 
2015). Activation of the hypoxia inducible 
pathway is known as the ‘hypoxic adaptive 
response’ and has extensively been investi-
gated in tumorigenesis as a mediator of tu-
mour growth, therapy resistance and metas-
tasis (Harris, 2002; Lu and Kang, 2010; Lin 
and Wu, 2015)  
Previous studies have shown that activa-
tion of the hypoxic pathway can induce ther-
apy resistance and is related to poor progno-
sis in primary liver tumours (Comerford et 
al., 2002; Paez-Ribes et al., 2009; Lu et al., 
2010; Liang et al., 2013; Luo et al., 2014; 
Yang et al., 2014). Furthermore, in humans, 
pre-operative trans-arterial chemoemboliz-
ation, which has been shown to induce a hy-
poxic adaptive response, has been linked to 
higher recurrence rates and a phenotypic 
switch from HCC to HCC-CC, with in-
creased expression of liver progenitor cell 
(LPC) characteristics (Zen et al., 2011; Zeng 
et al., 2012; Fang et al., 2013). In accord-
ance, we previously reported that inhibiting 
PHDs, (using a pan-PHD inhibitor or PHD2 
haplodeficient mice (PHD2+/-)), in murine di-
ethylnitrosamine (DEN)-induced hepatocel-
lular carcinoma (HCC), results in a more ag-
gressive mixed hepato-cholangiocarcinoma 
(HCC-CC) phenotype high in liver progeni-
tor cell (LPC) characteristics, coinciding 
with increased expression of markers for me-
tastasis and actors of the Notch signalling 
pathway (Heindryckx et al., 2012; Bogaerts 
et al., 2015). Possibly, PHD inhibition during 
carcinogenesis can readily prime future tu-
mour cells to react differently to later hypox-
ic stimuli, and give rise to more aggressive 
mixed phenotype cancers, with increased 
LPC characteristics and an increased risk for 
therapy resistance and metastasis (Bogaerts 
et al., 2014).  
LPCs are bipotential cells that reside in 
the canals of Hering in the liver, were they 
act as facultative adult stem cells (Spee et al., 
2010). In healthy liver, loss of hepatocyte or 
cholangiocyte cell mass can easily be re-
placed by the immense self-replicative ca-
pacity of the parenchyma. However, in situa-
tions of severely reduced liver function, like 
in chronic liver disease, the progenitor cell 
compartment is activated (Boulter et al., 
2012).  
LPCs then proliferate and migrate to the 
site of injury where they differentiate to re-
plenish the lost cell mass by a series of tight-
ly organised interactions controlled by the 
Notch and Wnt signalling pathways. Activa-
tion of the Notch pathway drives LPC’s to-
wards a cholangiocytic phenotype, while 
Wnt induced inhibition of Notch signalisa-
tion results in hepatic differentiation (Boulter 
et al., 2012). 
The Notch pathway not only plays a piv-
otal role in the cell- fate determination of 
LPCs, it is also shown to be an important 
mediator of hepatocarcinogenesis. Interest-
ingly, activation or inhibition of the different 
Notch receptors can have both pro- and anti- 
oncogenic effects (Dill et al., 2013; Ortica et 
al., 2014; Geisler and Strazzabosco, 2015; 
Huntzicker et al., 2015). In our previous 
studies, mRNA expression of actors of the 
Notch signalling pathway was increased in 
DEN induced HCC in which PHDs were in-
hibited. The Notch pathway could thus play 
a role in PHD inhibition-mediated expres-
sion of LPC characteristics, which would be 
an attractive therapeutic target.  
Since we observed increased expression 
of LPC characteristics by inhibiting PHD 
proteins during HCC development, which 
was associated with increased mRNA ex-
pression of actors of the Notch pathway, we 
aimed to investigate if the effect of PHD2 
haplodeficiency on liver tumour phenotype 
in advanced DEN induced HCC is preceded 
by altered LPC and/or Notch expression at 
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early stages of hepatocarcinogenesis. A bet-
ter understanding of the effect of hypoxic 
conditions early during tumour initiation and 
development, mimicked by PHD2 haplodefi-
ciency, a situation readily present during 
chronic liver disease and tumour relapse, 
could allow us to pinpoint critical markers 
and events involved in the observed hypoxia 
induced phenotypic switch, therapy re-
sistance and metastasis. 
 
MATERIALS AND METHODS 
Induction of hepatocarcinogenesis in PHD2 
haplodeficient mice 
PHD2+/- mice were obtained from the Ve-
salius Research Center (KUleuven, Leuven, 
Belgium). A heterozygous couple was used 
for breeding and offspring was genotyped 
using the following primers in a concentra-
tion of 10 µM:  
ACCTATGATCTCAGCATTTGGGAG, 
TCAGGACAGTGAAGCCTAGAAACT 
and  
AAATTCTAATCGTAGCTGATGTGAGC 
(Heindryckx et al., 2012). 
To investigate the effect of PHD2 hap-
lodeficiency on early hepatocarcinogenesis 
in mice, 5 week old PHD2+/- and wild type 
(WT) littermates (129S6 background) re-
ceived weekly intraperitoneal DEN injec-
tions (35 mg/kg, Sigma-Aldrich, Bornem, 
Belgium). This induces microscopic neo-
plastic cells after 15 weeks, macroscopic 
nodule formation at 20 weeks and HCC after 
25 weeks, which was previously reported by 
our group (Heindryckx et al., 2010). These 
mice were euthanized after the 5th, 10th, 15th 
and 17th week of DEN, before HCC nodules 
could form (Heindryckx et al., 2010). As we 
have previously shown that there is no dif-
ference between WT and PHD2+/- healthy 
mice (Heindryckx et al., 2012), we adminis-
tered weekly saline injections for 17 weeks 
to PHD2+/- mice as controls. 
Mice were euthanized at indicated time-
points by cervical dislocation, the liver was 
excised and divided for histology and qPCR 
analysis, respectively submerged in 4 % 
formaldehyde (Klinipath, Olen, Belgium) for 
paraffin embedding and stored at -80 °C in 
RNA later (Ambion, Thermo Fisher scien-
tific, Gent Belgium) for RNA extraction. 
All experiments were approved by the 
ethical committee for animal experiments at 
the faculty of medicine and health sciences 
of Ghent University Belgium (ECD13/61). 
 
Histological evaluation 
General morphology of liver tissue was 
assessed using Haematoxylin-Eosin, Sirius 
Red and Reticulin stainings on 5 µm sections 
of paraffin embedded tissue as routinely de-
scribed. Neoplasticity was defined as en-
larged cells with normal nucleus to cyto-
plasm ratio (n/c), small cells with increased 
n/c, enlarged pleomorphic nuclei, and binu-
cleation, (pre) neoplastic hepatocytic lesions 
were identified by loss of reticulin staining 
and sirius red staining was performed to 
identify potential cholangiocytic lesions 
marked by cholangiofibrosis, as previously 
described (Bogaerts et al., 2015).  
Cytokeratin 19 immunohistochemistry 
(1/200 in TBS, ab133496, RRID: 
AB_11155282, abcam, Cambridge, UK) was 
used to visualize structures of the cholangio-
cytic lineage as well as LPCs. Overall CK19 
immunoreactivity was measured using Cell 
D software (Olympus Imaging Solutions, 
Münster, Germany) and to evaluate the LPC 
response, 5 portal areas were centred at a 
magnification of 400 and all CK19 positive 
single cells were counted.  
 
Quantitative real time PCR (qPCR) 
RNA was extracted from 20 mg of frozen 
liver tissue preserved in RNA-later, accord-
ing to the manufacturer’s guidelines (Rneasy 
Mini Kit, Quiagen, Venlo, the Nederlands). 
cDNA was obtained from 1 µg RNA us-
ing the iScript cDNA synthesis kit (Bio-Rad, 
Nazareth-Eke, Belgium) and quantitative 
PCR (qPCR) analyses were performed using 
the Lightcycler 480 Green I master mix 
(Roche, Vilvoorde, Belgium), using the pri-
mersets listed in Table 1. 
All reactions were run in duplicate; the 
comparative Cq method was used to deter-
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mine the number of transcripts which were 
normalised to reference genes that showed 
stable expression in all samples, as also pre-
viously described (Heindryckx et al., 2012; 
Bogaerts et al., 2015).  
 
Statistical analysis 
Data were analysed using SPSS23 soft-
ware (IMB corp, Armonk NY, USA) and 
graphs were illustrated using Graphpad 
prism 6 software (Graphpad software, inc; 
San Diego CA, USA). Kolmogorov-Smirnov 
test was used to test for normality. Student’s 
T- test was then performed in case of nor-
mality; the Mann-Whitney-U test was used 
for not normally distributed data. P-values 
≤ 0.05 were considered significant. All data 
are presented as mean ±SEM. 
RESULTS 
PHD2 haplodeficiency does not alter the 
onset of neoplastic transformation  
We first assessed the effect of PHD2 hap-
lodeficiency on HIF stabilisation by as-
sessing the activation of HIF target genes. In 
early hepatocarcinogenesis, we did not ob-
serve a significant activation of the hypoxic 
pathway compared to saline control mice, in 
either genotype. However, HIF downstream 
targets showed a peak RNA expression after 
17 weeks of DEN compared to other time 
points (Figure 1A, C) and in PHD2+/- mice 
compared to WT mice at the same time-
point. (Figure 1B, C).  
 
 
Table 1: Primersets 
short Full name Forward primer Reversed primer 
Gapdh glyceraldehyde 3 phos-phate dehydrogenase CATGGCCTTCCGTGTTCCTA GCGGCACGTCAGATCCA 
Hmbs hydroxymethyl-bilane synthase AAGGGCTTTTCTGAGGCACC AGTGCCCATCTTTCATCACTG 
Hprt 
hypoxanthine guanine 
phosphoribosyl transfer-
ase 
GTTAAGCATACAGCCCCAAA AGGCATTCCAACAACAAACTT 
Sdha succinate dehydrogen-ase complex, subunit A CTTGAATGAGGCTGACTGTG ATCACATAAGCTGGTCCTGT 
Afp alpha – fetoprotein AGCTTCCACGTTGATCCTCC ACAAACTGGTAAAGGTGATGG
CK19 Cytokeratin 19 GTTCAGTACGCATGGGTCAG GAGGACGAGGTCACGAAGC 
Prom1 Prominin 1 CTCCCATCAGTGGTAGGAAC ATACCCCCTTTTGACGAGGCT 
EpCam Epithelial cell adhesion molecule GCGGCTCAGAGAGACTGTG CCAAGCATTTAGACGCCATTT 
Mdr1 Multi drug resistance protein 1 AGCCTAGAGGCTGAGGCCG TCACGTGCCACCTCCGGGTT 
Jag1 Jagged 1 ATGCAGAACGTGAATGGGAG GCGGGACTGATACTCCTTGAG
Notch1 Notch 1 GATGGCCTCAATGGTACAAG TCGTTGTTGTGATGTCACAGT 
Notch2 Neurogenic locus notch homolog protein 2 ATGTGGACGATGTCTGTTGC GGAAGCATAGGCACAGTCATC
Notch3 Neurogenic locus notch homolog protein 3 AGTGCCGATCTGTACAAGTT CACTACGGGGTTCTCACACA 
Hes1 Hairy enhancer of split 1 ACGTGCGAGGGCGTTAATAC ACGTGCGAGGGCGTTAATAC 
Vegfa Vascular endothelial growth factor A ACTCGGATGCCGACACGGA CCTGGCCTTGCTTGCTCCCC 
Glut1 Glucose transporter 1 GCTTATGGGCTTCTCCAAACT GTGACACCTCTCCCACATAC 
Pfk Phosphofructokinase GCCGGCTCAGTGAGACAAG TGGCACCTTCAGCAACAATG 
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Figure 1: mRNA expression of HIF target genes 
A. vascular endothelial growth factor alpha (Veg-
fa), B. phosphofructokinase (Pfk) and C. glucose 
transporter 1 (Glut1) in PHD2+/- and WT mice, eu-
thanised at different time points in hepatocarcin-
ogenesis. 
° p < 0.05, °° p < 0.01 and °°° p < 0.001 com-
pared to saline control mice 
* p < 0.05, ** p < 0.01 and *** p < 0.001 
 
 
To assess general morphology and neo-
plasia, haematoxylin-eosin, sirius red and re-
ticulin stainings were performed. Neoplastic 
cells and reticulin free hepatocytic plates 
could be observed from 10 weeks onwards 
(Figure S1) and neoplastic nodules were ob-
served from 15 weeks onwards (Figure S1). 
Sirius red staining was evaluated as previ-
ously described (Bogaerts et al., 2015), and 
showed no cholangiocytic lesions (Figure 
S1). No difference was observed between 
PHD2+/- and WT livers at the indicated time 
points. 
 
Neoplastic transformation coincides with 
increased expression of LPC characteristics 
during early hepatocarcinogenesis  
To evaluate the effect of PHD2 haplode-
ficiency on the expression of LPC character-
istics, we performed qPCR analysis of Cy-
tokeratin 19 (CK19), Prominin 1 (Prom1), 
Epithelial cell adhesion molecule (Epcam), 
Alpha fetoprotein (Afp) and multi drug re-
sistance protein 1 (MDR1).  
In the early pathogenesis of DEN in-
duced HCC, the mRNA expression of Ep-
cam and Afp was continuously upregulated 
in all DEN treated mice compared to saline 
control (Figure 2A, B), strengthening the ev-
idence for these characteristics as good 
markers of carcinogenesis (Chan et al., 2014; 
Gomaa et al., 2015). While no time depend-
ent, PHD2 haplodefiency- relate effect could 
be observed concerning Epcam mRNA ex-
pression (Figure 2A), Afp expression was 
significantly increased after 15 weeks in 
PHD2+/- mice compared to WT livers. How-
ever, this increased expression was not main-
tained after 17 weeks of DEN induction 
(Figure 2B). 
DEN treatment resulted in significantly 
increased Prom1 expression in PHD2+/- liv-
ers, compared to saline controls from 10 
weeks onwards (Figure 2D) which was not 
observed for CK19. No difference between 
PHD2+/- and WT counterparts could be ob-
served for CK19 and Prom1 expression at 
any time-point (Figure 2C, D). Interestingly 
CK19 and Prom1 mRNA showed a peak ex-
pression after 17 weeks of DEN compared to 
Saline control and all other time points of the 
same genotype (Figure 2C, D). 
Like Afp and Epcam, MDR1 mRNA ex-
pression was increased in all groups that re-
ceived DEN compared to saline control 
(Figure 2E). Furthermore, MDR1 expression 
was significantly increased after 15 and 17 
weeks of DEN, compared to all earlier time 
points in PHD2+/- mice and compared to WT 
counterparts, and differed significantly be-
tween 15 and 17 weeks of DEN in WT livers 
(Figure 2E).  
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Figure 2: mRNA expression of LPC markers 
A. epithelial cell adhesion molecule (Epcam), B. alpha feto-protein (Afp), C. cytokeratin 19 (CK19),  
D. prominin 1 (Prom1) and E. multi drug resistance protein 1 (MDR1) in PHD2+/- and WT mice 
° p < 0.05, °° p < 0.01 and °°° p < 0.001 compared to saline control mice 
* p < 0.05, ** p < 0.01 and *** p < 0.001 
 
 
Comparison of CK19 immunopositivity 
between PHD2+/- and WT mice at different 
time points in hepatocarcinogenesis showed 
an increased number of central vein concen-
trated CK19+ single cells after 15 and 17 
weeks of DEN (Figure 3B) and a tendency 
towards increased CK19 expression in 
PHD2+/- mice at week 15 and 17 compared to 
earlier time points and compared to WT 
counterparts (Figure 3B).  
 
Induction of the hypoxic adaptive response 
coincides with increased expression  
of Notch3 mRNA in early hepatocarcino-
genesis 
The Notch pathway plays a pivotal role 
in the cell-fate determination of LPCs and 
could also play a role in the increased ex-
pression of LPC characteristics observed af-
ter PHD inhibition. We therefore investigat-
ed the mRNA expression of Notch markers 
in early DEN- induced hepatocarcinogenesis 
in PHD2+/- and WT counterparts. 
We performed qPCR analysis of Notch 
receptors Notch1, 2 and 3, Notch ligand Jag-
ged 1 (Jag1) as well as the main Notch effec-
tor gene Hairy enhancer of split 1 (Hes1).  
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Figure 3: Cytokeratin 19 immunohistochemistry 
A. percent immunopositivity and average number of CK19 positive cells per portal area in PHD2+/- 
and WT counterparts at different time points in hepatocarcinogenesis B. CK19 immunopositive 
hepatocytes around the central vein after 15 week of DEN. 
CV: Central vein, P: Portal vein, Scale bars: 1000 µm, * p < 0.05, ** p < 0.01 and *** p < 0.001 
 
 
 
DEN treatment did not induce consistent 
effects on Notch1 and Notch2 mRNA ex-
pression (Figure 4A, B). Expression of 
Notch3, Hes1 and Jag1 mRNA was signifi-
cantly upregulated compared to saline con-
trol after 17 weeks of DEN in both WT and 
PHD2+/- livers which coincides with in-
creased expression of markers for hypoxia 
and HIF stabilisation (Figure 1, 4C, D, E). 
However, no difference could be observed 
between PHD2+/- and WT mice. After 17 
weeks mRNA expression of Notch3 and 
Jag1 was also significantly upregulated in 
PHD2+/- livers compared to same genotype 
livers at earlier time points (Figure 4C, D). 
 
DISCUSSION 
We have previously shown that in the 
DEN mouse model for hepatocarcinogenesis, 
PHD inhibition results in a mixed HCC-CC 
phenotype, high in LPC characteristics, 
which has been associated with a worse 
prognosis (Heindryckx et al., 2012; Bogaerts 
et al., 2015). In this study we aimed to inves-
tigate the effect of continuous PHD inhibi-
tion in early stages of hepatocarcinogenesis. 
We therefore used PHD2+/- mice that were 
euthanised at different time points to unravel 
the dynamics of PHD2 haplodeficiency dur-
ing early hepatocarcinogenesis, before nod-
ule formation.  
We observed that PHD2 haplodeficiency 
did not result in altered liver morphology or 
onset of neoplastic transformation compared 
to WT controls. After 17 weeks of DEN, we 
observed a peak expression of HIF target 
genes, which was more pronounced in 
PHD2+/- livers and coincided with the start of 
nodule formation as shown by histology. 
This allows the assumption that PHD hap-
lodeficiency only affects gene expression of 
HIF target genes in the presence of hypoxia.  
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Figure 4: mRNA expression of Notch receptors and Notch target genes 
A. Notch1, B. Notch2, C. Notch3, D. jagged 1 (Jag1) and E. hairy transcriptor of split 1 (HES1) and in 
PHD2+/- and WT mice, euthanised at different time points in hepatocarcinogenesis. 
°: p < 0.05, °°: p < 0.01 and °°°:p < 0.001 compared to saline control mice 
*:p < 0.05, **:p < 0.01 and ***:p < 0.001 
 
 
We found that Afp and Epcam mRNA 
expression was continuously upregulated, in 
all DEN treated mice, at all observed time 
points. Indeed, Afp and Epcam have been 
shown to be expressed in hepatocytes during 
embryogenesis and in cirrhotic and cancer-
ous livers (de Boer et al., 1999; Ruck et al., 
2000; Yamashita et al., 2008; Chan et al., 
2014; Gomaa et al., 2015). The mRNA ex-
pression of CK19, Prom1 peaked after 17 
weeks of DEN and coincided with increased 
expression of HIF target genes. Inherently to 
its microscopic structure, the liver can be di-
vided in 3 zones, reflecting the level of oxy-
genation, with the hepatocytes around the 
central vein most prone to oxygen depriva-
tion. The effects of PHD2 haplodeficiency 
will thus be most apparent in those cells. We 
did observe CK19+ hepatocytes around the 
central vein from 15 weeks onwards, further 
indicating that expression of CK19 could be 
related to increased HIF stabilisation. While 
it is unclear if CK19 and Prom1 expressing 
cells are progenitor cell derived (Govaere 
and Roskams, 2015), or dedifferentiated 
hepatocytes (Mu et al., 2015), recent studies 
have shown that increased CK19 and Prom1 
expression in HCC is related to prognosis 
(Song et al., 2008; Kim et al., 2011; Govaere 
et al., 2015) and recurrence (Song et al., 
2008; Zeng et al., 2012). 
Multi Drug resistance (MDR) proteins, 
which are inherently expressed by stem –and 
progenitor cells (Ros et al., 2003) are drivers 
of therapy resistance and have been shown 
upregulated in hypoxic conditions (Comer-
ford et al., 2002; Krishnamurthy et al., 
2004), attributing to the observed poor prog-
nosis for liver cancer with an increased pro-
genitor and/or hypoxic signature. Interesting-
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ly, MDR1 mRNA expression was increased 
in all DEN treated mice, compared to saline 
control and in PHD2+/- livers compared to 
WT counterparts from 15 weeks onwards, 
indicating that MDR1 could possibly be a 
marker for decreased PHD activity in early 
hepatocarcinogenesis. mRNA expression of 
MDR1 has, to our knowledge, not yet been 
mapped over time in animal models for 
hepatocarcinogenesis and its value as a po-
tential marker for ongoing tumorigenesis and 
increased hypoxic signalling has not yet been 
explored. 
Activation of the Notch signalling path-
way has been shown to be involved in liver 
and other cancers, with contradictory pro-
posed roles (Villanueva et al., 2012; 
Capaccione and Pine, 2013; Geisler et al., 
2015). Furthermore, while the distribution 
and prevalence of different Notch receptors 
have been reported in human healthy and 
diseased liver (Nijjar et al., 2001) and in a 
murine model for experimental HCC 
(Huntzicker et al., 2015), little is known 
about the expression of different Notch re-
ceptors in relation to phenotype and progno-
sis in experimental or human liver cancer.  
Inhibiting Notch 2 decreased HCC cell 
proliferation (Ortica et al., 2014) and tumour 
burden (Huntzicker et al., 2015), while 
Notch 1 and 2 overexpression in the liver re-
sulted in spontaneous HCC development 
with biliary or LPC characteristics 
(Villanueva et al., 2012; Dill et al., 2013; 
Zender et al., 2013). These observations are 
similar to the phenotype observed after PHD 
inhibition in HCC mice in previous studies 
(Heindryckx et al., 2012; Bogaerts et al., 
2015) and as in human tumours recurring af-
ter TACE treatment (Zen et al., 2011; Lai et 
al., 2015). In this study we could not show 
altered Notch1 or 2 receptor mRNA expres-
sion during early hepatocarcinogenesis. Yet, 
we previously showed increased Notch2 
mRNA expression, following PHD inhibi-
tion, associated with increased hepatocellular 
and cholangiocellular tumour burden at end 
stage DEN-induced carcinogenesis (Hein-
dryckx et al., 2012; Bogaerts et al., 2015). 
In PHD2+/- and WT mice, Notch3 expres-
sion peaked after 17 weeks of DEN, like 
CK19 and Prom1 mRNA expression, indi-
cating that expression of these markers coin-
cides with nodule formation. This is in line 
with previous data, were Notch3 overex-
pressing HCC cells were shown to have in-
creased aldehyde dehydrogenase activity 
(Zhang et al., 2015), characteristic for LPCs 
(Dolle et al., 2012) and inhibition was shown 
to overcome therapy resistance in HCC cells, 
increasing sorafenib toxicity (Giovannini et 
al., 2013).  
In conclusion, we used PHD2+/-mice to 
evaluate the effect of increased HIF stabilisa-
tion during early hepatocarcinogenesis. 
However, increased HIF signalling was only 
observed during nodule formation, coincid-
ing with increased mRNA expression of LPC 
characteristics and Notch3. We hypothesise 
that previously observed effects of increased 
HIF signalling on tumour phenotype mani-
fest during tumour growth rather than devel-
opment and are not preceded by an early 
LPC or Notch signature. Further elucidating 
possible mechanisms involved in this pro-
cess could help to develop new therapeutic 
strategies to improve prognosis of patients 
with tumours growing in a fibrotic back-
ground, or receiving hypoxia- inducing ther-
apies 
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Supplementary Figure 
 
 
Figure S1: Representative images for Haematoxylin-Eosin, Reticulin and Sirius red stainings showing 
different groups at different time points. We observe neoplastic cells from 10 weeks onwards and loss 
of reticulin from 15 weeks onwards in PHD2+/- and WT livers. Sirius red staining showed no presence 
of cholangiocytic lesions. Scale bars 2000 µm 
 
  
 
